United States· US:72903-853_47f1c78d-c469-4cd7-926e-51ce5b2d26f5
ELAHERE
A mirvetuximab soravtansine product containing mirvetuximab soravtansine, registered in United States by ImmunoGen, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Mirvetuximab soravtansine is registered in 13 of 19 countries.
Countries holding a registration under ATC L01FX26 (mirvetuximab soravtansine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Mirvetuximab soravtansine · ATC L01FX26
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MIRVETUXIMAB SORAVTANSINE
- Manufacturer
- ImmunoGen, Inc.
- Country
- United States (US)
- ATC code
- L01FX26
- ATC class
- Mirvetuximab soravtansine
- Defined daily dose
- 18 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1172903853011 VIAL, SINGLE-USE in 1 CARTON (72903-853-01) / 20 mL in 1 VIAL, SINGLE-USE
- ndc1172903-853-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mirvetuximab soravtansine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandElahere
- SpainELAHERE 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONAbbvie Deutschland Gmbh & Co. Kg
- BelgiumElahere 5 mg/mlAbbVie Deutschland
- CzechiaELAHEREAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- FinlandELAHEREAbbVie Deutschland GmbH&Co.KG
- FranceELAHERE 5 mg/mL, solution à diluer pour perfusionABBVIE DEUTSCHLAND (ALLEMAGNE)
- United KingdomElahere 100mg/20ml concentrate for solution for infusion vialsAbbVie Ltd
- IrelandELAHERE 5 mg/mL concentrate for solution for infusionImmunogen Biopharma (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Elahere
- Iceland · Elahere
- Liechtenstein · Elahere
- Norway · Elahere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9aedf81a-53f8-4633-9fa6-48565457e854 GET /v1/drugs/9aedf81a-53f8-4633-9fa6-48565457e854?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "5",
"substance": "MIRVETUXIMAB SORAVTANSINE",
"productndc": "72903-853",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761310",
"marketing_category": "BLA"
}See everything about mirvetuximab soravtansine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.